174 related articles for article (PubMed ID: 35447909)
1. Fucoxanthin Loaded in Palm Stearin- and Cholesterol-Based Solid Lipid Nanoparticle-Microcapsules, with Improved Stability and Bioavailability In Vivo.
Chen Y; He N; Yang T; Cai S; Zhang Y; Lin J; Huang M; Chen W; Zhang Y; Hong Z
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447909
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Fucoxanthin-Loaded Nanoparticles Composed of Casein and Chitosan with Improved Fucoxanthin Bioavailability.
Koo SY; Mok IK; Pan CH; Kim SM
J Agric Food Chem; 2016 Dec; 64(49):9428-9435. PubMed ID: 27960297
[TBL] [Abstract][Full Text] [Related]
3. Stability and biological activity enhancement of fucoxanthin through encapsulation in alginate/chitosan nanoparticles.
Sorasitthiyanukarn FN; Muangnoi C; Rojsitthisak P; Rojsitthisak P
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130264. PubMed ID: 38368987
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and physicochemical characterization of rhamnolipid fabricated fucoxanthin loaded bovine serum albumin nanoparticles supported by simulation studies.
Jaiswal J; Srivastav AK; Patel R; Kumar U
J Sci Food Agric; 2022 Sep; 102(12):5468-5477. PubMed ID: 35355263
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of starch/zein-based microcapsules for encapsulation and delivery of fucoxanthin.
Zhao Y; Zhi J; Huang S; Zhang X; Kim YR; Xu Y; Wang D; Luo K
Food Chem; 2022 Oct; 392():133282. PubMed ID: 35636187
[TBL] [Abstract][Full Text] [Related]
6. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
[TBL] [Abstract][Full Text] [Related]
7. Fucoxanthin@Polyvinylpyrrolidone Nanoparticles Promoted Oxidative Stress-Induced Cell Death in Caco-2 Human Colon Cancer Cells.
Sui Y; Gu Y; Lu Y; Yu C; Zheng J; Qi H
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33562511
[TBL] [Abstract][Full Text] [Related]
8. Nanoencapsulation enhances the bioavailability of fucoxanthin in microalga Phaeodactylum tricornutum extract.
Koo SY; Hwang KT; Hwang S; Choi KY; Park YJ; Choi JH; Truong TQ; Kim SM
Food Chem; 2023 Mar; 403():134348. PubMed ID: 36166925
[TBL] [Abstract][Full Text] [Related]
9. Engineering probiotics-derived membrane vesicles for encapsulating fucoxanthin: evaluation of stability, bioavailability, and biosafety.
Liang D; Liu C; Li J; Li Y; Li J; Tan M; Su W
Food Funct; 2023 Apr; 14(8):3475-3487. PubMed ID: 37000562
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
11. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
[TBL] [Abstract][Full Text] [Related]
12. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
Darwish MKM; El-Enin ASMA; Mohammed KHA
Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
[TBL] [Abstract][Full Text] [Related]
13. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in delivery systems of fucoxanthin.
Yuan Y; Ma M; Zhang S
Food Chem; 2023 Mar; 404(Pt B):134685. PubMed ID: 36279786
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
Sharma JB; Bhatt S; Saini V; Kumar M
Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
[No Abstract] [Full Text] [Related]
18. Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study.
Mok IK; Lee JK; Kim JH; Pan CH; Kim SM
Food Chem; 2018 Aug; 258():79-86. PubMed ID: 29655757
[TBL] [Abstract][Full Text] [Related]
19. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Oxidative Stability of Cold-pressed Sesame Oil Microcapsules Prepared by Complex Coacervation.
Dai HH; Li XD; Wei AC; Wang XD; Wang DY
J Oleo Sci; 2020 Jul; 69(7):685-692. PubMed ID: 32522944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
